These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28266528)

  • 21. Four indices on Gd-EOB-DTPA-enhanced MRI can estimate liver functional reserve compared to ICG-R15: A systematic review and meta-analysis.
    Ai X; Wang H; Yang Y; Feng Y; Xie X; Zhao X; Li J; Yao P; Zhu Q
    Clin Imaging; 2023 Oct; 102():1-8. PubMed ID: 37437466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic.
    Zhou ZP; Long LL; Qiu WJ; Cheng G; Huang LJ; Yang TF; Huang ZK
    Abdom Radiol (NY); 2017 Sep; 42(9):2272-2278. PubMed ID: 28396918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
    Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
    J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI.
    Yang M; Zhang Y; Zhao W; Cheng W; Wang H; Guo S
    BMC Med Imaging; 2020 Oct; 20(1):119. PubMed ID: 33081713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.
    Yamada A; Hara T; Li F; Fujinaga Y; Ueda K; Kadoya M; Doi K
    Radiology; 2011 Sep; 260(3):727-33. PubMed ID: 21712472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial.
    Geisel D; Raabe P; Lüdemann L; Malinowski M; Stockmann M; Seehofer D; Pratschke J; Hamm B; Denecke T
    Eur Radiol; 2017 Jul; 27(7):3080-3087. PubMed ID: 27966044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver function test by gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging with consideration of intrahepatic regional differences.
    Okubo H; Mogami M; Ozaki Y; Igusa Y; Aoyama T; Amano M; Kokubu S; Miyazaki A; Watanabe S
    Hepatogastroenterology; 2013 Oct; 60(127):1547-51. PubMed ID: 23933786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gd-EOB-DTPA-enhanced MRI T1 mapping for assessment of liver function in rabbit fibrosis model: comparison of hepatobiliary phase images obtained at 10 and 20 min.
    Zhou ZP; Long LL; Huang LJ; Yang TF; Huang ZK
    Radiol Med; 2017 Apr; 122(4):239-247. PubMed ID: 28070844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).
    Motosugi U; Ichikawa T; Sou H; Sano K; Ichikawa S; Tominaga L; Araki T
    J Magn Reson Imaging; 2009 Oct; 30(4):849-54. PubMed ID: 19787734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla.
    Zhang W; Wang X; Miao Y; Hu C; Zhao W
    Abdom Radiol (NY); 2018 Sep; 43(9):2262-2269. PubMed ID: 29476347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multivariable analysis of clinical influence factors on liver enhancement of Gd-EOB-DTPA-enhanced 3T MRI.
    Verloh N; Haimerl M; Zeman F; Teufel A; Lang S; Stroszczynski C; Fellner C; Wiggermann P
    Rofo; 2015 Jan; 187(1):29-35. PubMed ID: 25531338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice.
    Yamada T; Obata A; Kashiwagi Y; Rokugawa T; Matsushima S; Hamada T; Watabe H; Abe K
    Magn Reson Imaging; 2016 Jul; 34(6):724-729. PubMed ID: 26979540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.
    Wang LL; Li JF; Lei JQ; Guo SL; Li JK; Xu YS; Dou Y
    Medicine (Baltimore); 2021 May; 100(20):e25804. PubMed ID: 34011043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
    Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
    World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    Vanhooymissen IJSML; Thomeer MG; Braun LMM; Gest B; van Koeverden S; Willemssen FE; Hunink M; De Man RA; Ijzermans JN; Dwarkasing RS
    J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the Diagnosis and Treatment of Patients with Early-Stage Hepatocellular Liver Cancer by Multi-Row Spiral CTMDCT and Gd-EOB-DTPA-Enhanced MRI.
    Wang K; Jin X; Zhou J; Wang Z; Zhang X
    Altern Ther Health Med; 2024 Jan; 30(1):31-35. PubMed ID: 37773658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lobe-Based Hepatic Uptake Index of Gd-EOB-DTPA on Contrast-Enhanced MRI to Quantitatively Discriminate between Compensated and Decompensated Hepatitis B-Related Cirrhosis.
    Lu F; Tan B; Huang Y; Xu L; Wu C; Zhou H; Li R; Zhang X; Chen T; Li H
    Can J Gastroenterol Hepatol; 2024; 2024():6623848. PubMed ID: 38947874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the Magnetic Field Strength on Image Contrast in Gd-EOB-DTPA-enhanced MR Imaging: Comparison between 1.5T and 3.0T.
    Hata H; Inoue Y; Nakajima A; Komi S; Miyatake H
    Magn Reson Med Sci; 2017 Apr; 16(2):109-114. PubMed ID: 27151747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.